U.S. Surgical Snare Market Size, Share & Forecast 2026–2032
Report Highlights
- ✓Country: United States
- ✓Market: Surgical Snare Market
- ✓Market Size 2024: USD 310 million
- ✓Market Size 2032: USD 520 million
- ✓CAGR: 6.7%
- ✓Base Year: 2025
- ✓Forecast Period: 2026–2032
Analyst Recommendation — Secure GPO access early: Foreign manufacturers entering U.S. snare supply should file 510(k) submissions for cold and hot variants by Q3 2026, then secure Premier and Vizient group purchasing contracts before 2027. Pricing access depends on GPO contracts locking in volume.
U.S. Surgical Snares: Market Overview
U.S. surgical snares differ from the global market because demand is anchored in one dominant procedure, colonoscopy polypectomy, and in a reimbursement system that pays per procedure. The market generated an estimated USD 310 million in 2024, roughly a quarter of worldwide snare revenue. Purchasing runs through hospitals, ambulatory surgery centers and gastroenterology practices rather than the public tenders that define much of European demand.
Single-use devices account for the large majority of U.S. units, so the market behaves like a consumables business rather than a capital equipment cycle. Revenue tracks endoscopy procedure volume, which makes unit pricing and procedure mix more important than hardware replacement. Monofilament snares remain the workhorse for standard polyps, while cold snares are gaining share for diminutive lesions under 10 mm as endoscopists adopt resection techniques recommended by the American Society for Gastrointestinal Endoscopy.
Growth Drivers in U.S. Surgical Snares
The first driver is screening expansion. The U.S. Preventive Services Task Force lowered the recommended colorectal cancer screening start age to 45 in 2021, and Section 2713 of the Public Health Service Act requires private insurers to cover recommended screening without cost-sharing, pulling roughly 20 million additional adults into the screening pool. Each positive finding is a candidate for snare polypectomy, so colonoscopy volume converts directly into device demand.
The second driver is demographic and site-of-care migration. Adults aged 65 and older number roughly 61 million, and Medicare beneficiaries carry the highest polyp burden, while CMS has kept gastrointestinal endoscopy on the ASC covered procedures list. The third driver is the shift to single-use devices in infection-control protocols, where hospitals adopt disposable snares to reduce reprocessing liability and staff time.
Market Restraints and Entry Barriers
Regulatory timelines and trade costs raise the entry bar. Snares are cleared through FDA's 510(k) pathway under 21 CFR 876.4300, and the Quality Management System Regulation, which aligns 21 CFR Part 820 with ISO 13485:2016 from February 2, 2026, requires manufacturers to re-verify design controls. Section 301 tariffs on many China-origin medical devices add cost pressure for low-priced snares sourced from Asian contract manufacturers.
Incumbent bundling and purchasing power constrain new entrants. Olympus and Boston Scientific sell snares alongside endoscopes and processors, and Premier and Vizient group purchasing agreements typically lock hospital volume for multi-year terms. Entrants without a bundled capital relationship must negotiate price concessions against established contracts, while ASC buyers apply constant pressure on per-unit disposable costs.
Market Opportunities in U.S. Surgical Snares
Freestanding ASCs represent the most accessible near-term opportunity. More than 5,000 Medicare-certified ASCs perform endoscopy, and many gastroenterology-focused facilities buy snares through distributors rather than negotiated GPO agreements, lowering the contracting barrier. Addressable U.S. colonoscopy volume is estimated near 15 million procedures annually, and entrants offering cold-snare kits for diminutive polyps can target an estimated USD 95 million segment within ASC channels.
Bronchoscopy and urology provide adjacent openings. Snare-based retrieval in these specialties remains under-penetrated relative to colonoscopy, and specialty kits for these channels can be sold without displacing existing gastroenterology contracts. Entrants that complete GUDID registration and UDI-compliant labelling by 2027 will access hospital systems expanding their endoscopy standardisation programmes.
Market at a Glance
| Indicator | Detail |
|---|---|
| Market Size 2024 | USD 310 million |
| Market Size 2032 | USD 520 million |
| Growth Rate (CAGR) | 6.7% |
| Most Critical Decision Factor | Securing GPO contract access and 510(k) clearance timing |
| Largest Region | South Census Region |
| Competitive Structure | Consolidated, with top three suppliers holding a majority of unit share |
Leading Market Participants
- Boston Scientific
- Olympus Corporation of the Americas
- Cook Medical
- Medtronic
- Micro-Tech Endoscopy
- Ambu
- ERBE USA
- Medi-Globe
- Conmed
- Ethicon
Regulatory and Policy Environment
The FDA classifies endoscopic snares as Class II devices, with most cleared through 510(k) under 21 CFR 876.4300. The Medical Device User Fee Amendments (MDUFA V) set the standard FY2025 510(k) fee at USD 24,335, and FDA's review goal is 90 FDA days, although total clearance time often extends to six to nine months once holds are included. The Unique Device Identification rule under 21 CFR Part 830 requires GUDID submission and labelling for each device SKU.
CMS governs reimbursement through the Medicare Physician Fee Schedule, where CPT 45385 covers colonoscopy with snare removal, and through the ASC Covered Procedures List, updated annually in the Federal Register after a 60-day comment period. The Office of the U.S. Trade Representative administers Section 301 duties on China-origin devices, while the HHS Office of Inspector General enforces the Anti-Kickback Statute against distributor rebates and free-goods programmes.
Long-Term Outlook for U.S. Surgical Snares
By 2032 the U.S. surgical snare market will reach USD 520 million at a 6.7% CAGR. Growth will concentrate in ASCs and office-based gastroenterology, where single-use cold and hot snares increasingly form standardised procedure trays.
Competitive intensity will rise as lower-priced Asian manufacturers such as Micro-Tech Endoscopy expand U.S. distribution, pressuring mid-tier suppliers. Boston Scientific and Olympus will defend hospital contracts through endoscope bundling, while independent distributors will capture ASC accounts that lack GPO affiliation.
Frequently Asked Questions
Market Segmentation
- Colorectal Polypectomy
- Upper Gastrointestinal Resection
- Bronchoscopic Retrieval
- Urological Retrieval
- Others
- Hospitals
- Ambulatory Surgery Centers
- Gastroenterology Practices
- Academic Medical Centers
- Others
- Direct Hospital Sales
- Independent Distributors
- Group Purchasing Organizations
- Online Medical Supply Platforms
Table of Contents
Research Framework and Methodological Approach
Information
Procurement
Information
Analysis
Market Formulation
& Validation
Overview of Our Research Process
MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.
1. Data Acquisition Strategy
Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.
- Company annual reports & SEC filings
- Industry association publications
- Technical journals & white papers
- Government databases (World Bank, OECD)
- Paid commercial databases
- KOL Interviews (CEOs, Marketing Heads)
- Surveys with industry participants
- Distributor & supplier discussions
- End-user feedback loops
- Questionnaires for gap analysis
Analytical Modeling and Insight Development
After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.
2. Market Estimation Techniques
MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.
Bottom-up Approach
Aggregating granular demand data from country level to derive global figures.
Top-down Approach
Breaking down the parent industry market to identify the target serviceable market.
Supply Chain Anchored Forecasting
MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.
Supply-Side Evaluation
Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.
3. Market Engineering & Validation
Market engineering involves the triangulation of data from multiple sources to minimize errors.
Extensive gathering of raw data.
Statistical regression & trend analysis.
Cross-verification with experts.
Publication of market study.
Client-Centric Research Delivery
MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.